ReachMD
Be part of the knowledge.™Combating the Complexities of Cancer Care During Pregnancy
Project Oncology®Combating the Complexities of Cancer Care During Pregnancy
Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm
Project Oncology®Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm
Managing Immunotherapy Toxicities in Lung Cancer Patients
Spotlight on Lung CancerManaging Immunotherapy Toxicities in Lung Cancer Patients
Selecting Therapy for ER+/HER2- Metastatic Breast Cancer: Key Factors to Consider
Project Oncology®Selecting Therapy for ER+/HER2- Metastatic Breast Cancer: Key Factors to Consider
A Review of the Multiple Myeloma Treatment Journey
Project Oncology®A Review of the Multiple Myeloma Treatment Journey
Reevaluating Platinum Rechallenge in SCLC: Challenging the Status Quo
Project Oncology®Reevaluating Platinum Rechallenge in SCLC: Challenging the Status Quo
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
CME/CE Live BroadcastUnderstanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
June 19, 2023
11:00 AM - 12:00 PM EDT
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
CME/CE Live BroadcastUnderstanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
June 21, 2023
03:00 PM - 04:00 PM EDT
Targeting HER3 in Breast and Lung Cancers: Where We Are and Where We Are Going
CME/CETargeting HER3 in Breast and Lung Cancers: Where We Are and Where We Are Going
The Oncogenic Significance – and Promise – of HER3 in Pharmacotherapy
CME/CEThe Oncogenic Significance – and Promise – of HER3 in Pharmacotherapy
Better Early Than Late: CDK4/6 Inhibition in HR+, HER2- Early Breast Cancer
CME/CEBetter Early Than Late: CDK4/6 Inhibition in HR+, HER2- Early Breast Cancer
Keeping Pace in Lung Cancer
Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)CME/CEKeeping Pace in Lung Cancer
Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)
Operational Pathways for Biomarker Testing in NSCLC
Medical Industry FeatureOperational Pathways for Biomarker Testing in NSCLC
A Medical Oncologist Discusses a Treatment Option for Triple-Negative Breast Cancer
Medical Industry FeatureA Medical Oncologist Discusses a Treatment Option for Triple-Negative Breast Cancer
A Changing Paradigm for Cancer Screening: Exploring Surrogate Endpoints for an Urgent Public Health Concern
Project Oncology®A Changing Paradigm for Cancer Screening: Exploring Surrogate Endpoints for an Urgent Public Health Concern
Understanding Unmet Needs in the Frontline Ph+ ALL Treatment Landscape
Medical Industry FeatureUnderstanding Unmet Needs in the Frontline Ph+ ALL Treatment Landscape
First-Line Treatment Option for Certain Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Medical Industry FeatureFirst-Line Treatment Option for Certain Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Patient Journeys: An Individualized Approach to Statin Treatment for Adult Patients
Medical Industry FeaturePatient Journeys: An Individualized Approach to Statin Treatment for Adult Patients
lsu.edu
06/09/2023- news.uthscsa.edu
06/09/2023
- nytimes.com
06/09/2023
- miragenews.com
06/09/2023
- newswise.com
06/08/2023
- mdanderson.org
06/07/2023